Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CM007406-006
Application #
3608368
Study Section
Project Start
1980-09-15
Project End
1984-10-31
Budget Start
1984-10-31
Budget End
1984-01-14
Support Year
Fiscal Year
1985
Total Cost
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
Hospitals
DUNS #
001910777
City
Houston
State
TX
Country
United States
Zip Code
77030
Ajani, J A; Abbruzzese, J L; Faintuch, J S et al. (1988) Phase II study of fludarabine phosphate in patients with advanced colorectal carcinoma. Invest New Drugs 6:47-50
Ajani, J A; Hortobagyi, G N; Frye, D et al. (1987) A randomized study of two schedules of copovithane in patients with advanced colorectal carcinoma. Am J Clin Oncol 10:139-40
Adolphson, C C; Ajani, J A; Stroehlein, J R et al. (1986) Phase II trial of acivicin in patients with advanced colorectal carcinoma. Am J Clin Oncol 9:189-91
Ajani, J A; Faintuch, J S; McClure, R K et al. (1986) Phase II study of spirogermanium in patients with advanced colorectal carcinoma. Invest New Drugs 4:383-5
Dhingra, H M; Umsawasdi, T; Chiuten, D F et al. (1986) Phase II study of spirogermanium in advanced (extensive) non-small cell lung cancer. Cancer Treat Rep 70:673-4
Kavanagh, J J; Saul, P B; Copeland, L J et al. (1985) Continuous-infusion spirogermanium for the treatment of refractory carcinoma of the ovary: a phase II trial. Cancer Treat Rep 69:139-40